Basal Cell Carcinoma Clinical Trials

217 clinical trials for Basal Cell Carcinoma across international registries, including 23 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer — RECRUITING · PHASE1
• Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors — RECRUITING · PHASE1
• The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas — RECRUITING · PHASE2
• Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma — RECRUITING · PHASE2
• Dermatologic Avatar LLM-based Anamnesis Study — RECRUITING
• AI-Based Risk Classification and Histopathological Subtype Prediction of Basal Cell Carcinoma Using Dermoscopic Images — RECRUITING
• Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT) — RECRUITING · NA
• Pilot Study of Line-Field Confocal Optical Coherence Tomography for Detection of Mohs Micrographic Surgery Margins of Basal Cell Carcinomas — RECRUITING · NA
• Raman Spectroscopy and Skin Cancer — RECRUITING
• Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma — RECRUITING · PHASE2
• Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) Patients — RECRUITING · PHASE2
• Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas — RECRUITING · PHASE1
• Radiotherapy by Sonic Hedgehog Pathway Inhibitors in Basal Cell Carcinoma — RECRUITING · PHASE2
• Personalised Immunotherapy Platform — RECRUITING
• Intraoperative Confocal Laser Scanning Microscopy With Use of AI for Optimized Surgical Excision of Basal Cell Carcinoma — RECRUITING
• A Beta-only IL-2 ImmunoTherapY Study — RECRUITING · PHASE1
• Skin Cancer and Hyperthermia and Radiotherapy — RECRUITING · NA
• Retrospective and Prospective Observational Study in Patients With Advanced Basal Cell Carcinoma — RECRUITING
• Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study — RECRUITING
• Investigation of Standard Excision Surgical Margins Using Two Photon Fluorescence Microscopy — RECRUITING · NA
• Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients with Advanced NMSC — RECRUITING
• To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma — RECRUITING · PHASE2
• A PHASE 2 STUDY OF REGN2810, A FULLY HUMAN MONOCLONAL ANTIBODY TO PROGRAMMED DEATH-1, IN PATIENTS WITH ADVANCED BASAL CELL CARCINOMA WHO EXPERIENCED PROGRESSION OF DISEASE ON HEDGEHOG PATHWAY INHIBITOR THERAPY, OR WERE INTOLERANT OF PRIOR HEDGEHOG PATHWAY INHIBITOR THERAPY — RECRUITING · PHASE2
• FLUORESCENT DETECTION WITH METHYL AMINOLEVULINATE OF BASAL CELL CARCINOMA: TO ASSESS THE ACCURACY OF THIS TECHNIQUE BY COMPARISON WITH RESECTION MARGIN LEFT BY MOH’S MICROGRAPHIC SURGERY AFTER DIFFERENT APPLICATION TIMES OF THE METHYL AMINOLEVULINATE — COMPLETED · PHASE4
• A trial comparing Metvix® photodynamic therapy (PDT) followed by Mohs micrographic surgery with Mohs micrographic surgery alone for the treatment of basal cell carcinoma (BCC) — TERMINATED · PHASE4
• A Study of Observation and Follow-up in People With Basal Cell Carcinoma — ACTIVE_NOT_RECRUITING
• Impact of Dysport on PMFF Donor Scar — NOT_YET_RECRUITING · PHASE4
• Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO — ACTIVE_NOT_RECRUITING · PHASE3
• Evaluation of efficacy and safety of Cemiplimab as first line treatment for advanced basal cell carcinoma (CEMI-first) - An open label, single arm, prospective phase II trial of the DeCOG network — TERMINATED · PHASE2
• In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma — COMPLETED · PHASE2
• Nivolumab and Ipilimumab in Treating Patients With Rare Tumors — ACTIVE_NOT_RECRUITING · PHASE2
• Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery — SUSPENDED · PHASE2
• A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer — TERMINATED · PHASE2
• Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy — ACTIVE_NOT_RECRUITING · PHASE2
• Flash Radiotherapy for Skin Cancer — NOT_YET_RECRUITING · PHASE2
• A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) in Patients With Advanced Basal Cell Carcinoma — COMPLETED · PHASE2
• Basal Cell Carcinoma Chemoprevention Trial — NOT_YET_RECRUITING · PHASE3
• A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study — COMPLETED · PHASE2
• Inter-Operator Variability in the Clinical Staging and Therapeutic Management of Basal Cell Carcinoma — NOT_YET_RECRUITING
• Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies — ACTIVE_NOT_RECRUITING · PHASE1
• Study Evaluating the Interest of Vismodegib as Neo-adjuvant Treatment of Basal Cell Carcinoma (BCC) — COMPLETED · PHASE2
• A Study on Radiation Therapy Guided by the Reflectance Confocal Microscopy (RCM)/Optical Coherence Tomography (OCT) Device in People With Basal Cell Carcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• SPOTLIGHT 204: A Multicenter, Phase 2b, open-label, non-randomized, clinical trial to evaluate safety, tolerability and preliminary efficacy of intra-lesional BO-112 in patients with resectable primary low and high risk basal cell carcinoma — TERMINATED · PHASE2
• Dose Escalation Trial to Evaluate Dose Limiting Toxicity/Maximum Tolerated Dose of Microneedle Arrays Containing Doxorubicin (D-MNA) in Basal Cell Carcinoma (BCC) — TERMINATED · PHASE1
• Investigation of Mohs Surgical Margins Using Two Photon Microscopy — COMPLETED · NA
• FLASH Radiotherapy for Skin Cancer — ACTIVE_NOT_RECRUITING · NA
• Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma — ACTIVE_NOT_RECRUITING · NA
• CivaDerm(TM) Surface Therapy Pilot Study — COMPLETED · PHASE1
• BCC-One-Stop-Study — NOT_YET_RECRUITING · NA

Refine this search